Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non‑tuberculous mycobacteria: A case report and review of the literature

Inagaki,Noriko; Kibata,Kayoko; Tamaki,Takeshi; Shimizu,Toshiki; Nomura,Shosaku

doi:10.3892/ol.2013.1461

Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non‑tuberculous mycobacteria: A case report and review of the literature

Authors:
- Noriko Inagaki
- Kayoko Kibata
- Takeshi Tamaki
- Toshiki Shimizu
- Shosaku Nomura
View Affiliations

Affiliations: First Department of Internal Medicine, Kansai Medical University, Moriguchi, Osaka 570‑8506, Japan
Published online on: July 15, 2013 https://doi.org/10.3892/ol.2013.1461
Pages: 676-680

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Primary intrahepatic malignant mesothelioma (PIHMM) is an extremely rare tumor with clinicopathological characteristics that remain to be elucidated. The current study presents the case of a 68‑year‑old female with PIHMM and multiple lymphadenopathies due to non‑tuberculous mycobacteria. The patient presented with an intrahepatic tumor, 70 mm in diameter, in the right lobe of the liver. An ultrasound‑guided fine‑needle aspiration biopsy of the liver tumor revealed findings that were consistent with an intrahepatic malignant mesothelioma. The systemic lymph node swellings were due to epithelioid granulomas that were caused by non‑tuberculous mycobacteria. However, a hepatic rupture occurred due to the rapid growth of the liver tumor and consequently, a surgical resection was not performed. A review of the literature revealed that the clinicopathological characteristics of PIHMM are similar to those of non‑occupational mesothelioma. However, PIHMM is usually a solitary tumor and is rarely associated with cavity effusion in contrast with conventional mesothelioma. Therefore, surgical resection with curative intent is often recommended for patients with PIHMM.

View Figures

View References

1	Maitra A and Kumar V: The lung and upper respiratory tract. Robbins Basic Pathology. 7th edition. Saunders; Philadelphia: pp. 453–509. 2002
2	Battifora H and McCaughey E: Tumors of the Serosal Membranes. Armed Forces Institute of Pathology; Washington, DC: 1994
3	Thomason R, Schlegel W, Lucca M, et al: Primary malignant mesothelioma of the pericardium. Case report and literature review. Tex Heart Inst J. 21:170–174. 1994.PubMed/NCBI
4	Kasdon EJ: Malignant mesothelioma of the tunica vaginalis propria testis. Report of two cases Cancer. 23:1144–1150. 1969.PubMed/NCBI
5	Kozlowski H and Zoltowska A: Mesothelioma of spermatic cord. Neoplasma. 15:97–100. 1968.PubMed/NCBI
6	Imura J, Ichikawa K, Takeda J, Iwasaki Y, et al: Localized malignant mesothelioma of the epithelial type occurring as a primary hepatic neoplasm: a case report with review of the literature. APMIS. 110:789–794. 2002. View Article : Google Scholar : PubMed/NCBI
7	Leonardou P, Semelka RC, Kanematsu M, et al: Primary malignant mesothelioma of the liver: MR imaging findings. Magn Reson Imaging. 21:1091–1093. 2003. View Article : Google Scholar : PubMed/NCBI
8	Gütgemann I, Standop J and Fischer HP: Primary intrahepatic malignant mesothelioma of epithelioid type. Virchows Arch. 448:655–658. 2006.PubMed/NCBI
9	Kim DS, Lee SG, Jun SY, et al: Primary malignant mesothelioma developed in liver. Hepatogastroenterology. 55:1081–1084. 2008.PubMed/NCBI
10	Sasaki M, Araki I, Yasui T, et al: Primary localized malignant biphasic mesothelioma of the liver in a patient with asbestosis. World J Gastroenterol. 15:615–621. 2009. View Article : Google Scholar : PubMed/NCBI
11	Buchholz BM, Gütgemann I, Fischer HP, et al: Lymph node dissection in primary intrahepatic malignant mesothelioma: case report and implications for diagnosis and therapy. Langenbecks Arch Surg. 394:1123–1130. 2009. View Article : Google Scholar : PubMed/NCBI
12	Husain AN, Colby TV, Ordóñez NG, et al: Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 133:1317–1331. 2009.PubMed/NCBI
13	Yates DH, Corrin B, Stidolph PN and Browne K: Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax. 52:507–512. 1997.PubMed/NCBI
14	Borasio P, Berruti A, Billé A, et al: Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg. 33:307–313. 2008. View Article : Google Scholar : PubMed/NCBI
15	Gemba K, Fujimoto N, Kato K, et al: National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci. 103:483–490. 2012. View Article : Google Scholar : PubMed/NCBI
16	Law MR, Hodson ME and Heard BE: Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax. 37:810–815. 1982. View Article : Google Scholar : PubMed/NCBI
17	Abdel Rahman AR, Gaafar RM, Baki HA, et al: Prevalence and pattern of lymph node metastasis in malignant pleural mesothelioma. Ann Thorac Surg. 86:391–395. 2008.PubMed/NCBI
18	Edwards JG, Stewart DJ, Martin-Ucar A, et al: The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg. 131:981–987. 2006. View Article : Google Scholar : PubMed/NCBI
19	Metintas M, Metintas S, Ak G, et al: Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure. Respirology. 13:117–121. 2008. View Article : Google Scholar : PubMed/NCBI
20	Saad RS, Lindner JL, Lin X, et al: The diagnostic utility of D2–40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement. Diagn Cytopathol. 34:801–806. 2006.
21	Ordóñez NG: The immunohistochemical diagnosis of mesothelioma: A comparative of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol. 27:1031–1051. 2003.PubMed/NCBI
22	Roberts F, Harper CM, Downie I and Burnett RA: Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies. Am J Clin Pathol. 116:253–262. 2001. View Article : Google Scholar : PubMed/NCBI
23	Pu RT, Pang Y and Michael CW: Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions. Diagn Cytopathol. 36:20–25. 2008. View Article : Google Scholar : PubMed/NCBI
24	Moch H, Oberholzer M, Christen H, et al: Diagnostic tools for differentiating pleural mesothelioma from lung adenocarcinoma in paraffin embedded tissue. II Design of an expert system and its application to the diagnosis of mesothelioma. Virchows Arch A Pathol Anat Histopathol. 423:493–496. 1993. View Article : Google Scholar : PubMed/NCBI
25	Attanoos RL and Gibbs AR: Pathology of malignant mesothelioma. Histopathol. 30:403–418. 1997. View Article : Google Scholar : PubMed/NCBI
26	Tot T: The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinoma from pleural mesotheliomas. Cancer. 92:2727–2732. 2001. View Article : Google Scholar : PubMed/NCBI
27	Wang NP, Zee S, Zarbo RJ, et al: Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem. 3:99–107. 1995.
28	Chu P, Wu E and Weiss LM: Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 13:962–972. 2000. View Article : Google Scholar : PubMed/NCBI
29	Treglia G, Taralli S, Calcagni ML, et al: Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review. J Comput Assist Tomogr. 35:387–393. 2011. View Article : Google Scholar
30	Das CJ, Kumar R, Balakrishnan VB, et al: Disseminated tuberculosis masquerading as metastatic breast carcinoma on PET-CT. Clin Nucl Med. 33:359–361. 2008. View Article : Google Scholar : PubMed/NCBI
31	Li YJ, Cai L, Sun HR, et al: Increased FDG uptake in bilateral adrenal tuberculosis appearing like malignancy. Clin Nucl Med. 33:191–192. 2008. View Article : Google Scholar : PubMed/NCBI
32	Lin WY, Hung GU and Tsai SC: A pitfall of FDG-PET image interpretation: accumulation of FDG in the dependent area of the urinary bladder after bladder irrigation - the usefulness of the prone position. Clin Nucl Med. 30:638–639. 2005. View Article : Google Scholar : PubMed/NCBI